TOKYO - A Japanese health ministry panel approved Wednesday the administration of U.S. biotechnology firm Moderna Inc.'s COVID-19 booster shots at least six months after an individual aged 18 or older has received their second dose.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
